Correlation Between Fusion Pharmaceuticals and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fusion Pharmaceuticals and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fusion Pharmaceuticals and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fusion Pharmaceuticals and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Fusion Pharmaceuticals and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fusion Pharmaceuticals with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fusion Pharmaceuticals and Salarius Pharmaceuticals.
Diversification Opportunities for Fusion Pharmaceuticals and Salarius Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Fusion and Salarius is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Fusion Pharmaceuticals and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Fusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fusion Pharmaceuticals are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Fusion Pharmaceuticals i.e., Fusion Pharmaceuticals and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fusion Pharmaceuticals and Salarius Pharmaceuticals
If you would invest 152.00 in Salarius Pharmaceuticals on December 29, 2024 and sell it today you would lose (66.00) from holding Salarius Pharmaceuticals or give up 43.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Fusion Pharmaceuticals vs. Salarius Pharmaceuticals
Performance |
Timeline |
Fusion Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Salarius Pharmaceuticals |
Fusion Pharmaceuticals and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fusion Pharmaceuticals and Salarius Pharmaceuticals
The main advantage of trading using opposite Fusion Pharmaceuticals and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fusion Pharmaceuticals position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.Fusion Pharmaceuticals vs. Bicycle Therapeutics | Fusion Pharmaceuticals vs. Relmada Therapeutics | Fusion Pharmaceuticals vs. RAPT Therapeutics | Fusion Pharmaceuticals vs. NewAmsterdam Pharma |
Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics | Salarius Pharmaceuticals vs. GeoVax Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |